US57060D1081 - Common Stock

**MKTX** gets a fundamental rating of **6** out of 10. The analysis compared the fundamentals against 208 industry peers in the **Capital Markets** industry. **MKTX** has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. **MKTX** is valied quite expensively at the moment, while it does show a decent growth rate. These ratings could make **MKTX** a good candidate for quality investing.

In the past year **MKTX** had a positive cash flow from operations.

The **Average Return On Invested Capital** over the past 3 years for **MKTX** is significantly above the industry average of **9.80%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 14.25% | ||

ROE | 20.79% | ||

ROIC | 20.02% |

ROA(3y)15.07%

ROA(5y)17.83%

ROE(3y)22.62%

ROE(5y)25.16%

ROIC(3y)21.91%

ROIC(5y)23.98%

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 43.06% | ||

PM (TTM) | 33.77% | ||

GM | 91.86% |

OM growth 3Y-8.35%

OM growth 5Y-3.02%

PM growth 3Y-7.59%

PM growth 5Y-2.88%

GM growth 3Y-1.21%

GM growth 5Y-0.61%

The number of shares outstanding for **MKTX** has been increased compared to 1 year ago.

There is no outstanding debt for **MKTX**. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | 0 | ||

Altman-Z | 11.36 |

ROIC/WACCN/A

WACCN/A

A Current Ratio of **2.11** indicates that **MKTX** has no problem at all paying its short term obligations.

A Quick Ratio of **2.11** indicates that **MKTX** has no problem at all paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.11 | ||

Quick Ratio | 2.11 |

The **Earnings Per Share** has been growing slightly by **2.33%** over the past year.

The **Earnings Per Share** has been growing by **9.21%** on average over the past years. This is quite good.

Looking at the last year, **MKTX** shows a small growth in **Revenue**. The Revenue has grown by **3.93%** in the last year.

EPS 1Y (TTM)2.33%

EPS 3Y-3.29%

EPS 5Y9.21%

EPS growth Q2Q-7.59%

Revenue 1Y (TTM)3.93%

Revenue growth 3Y2.98%

Revenue growth 5Y11.56%

Revenue growth Q2Q0.12%

EPS Next Y9.5%

EPS Next 2Y11.48%

EPS Next 3Y11.87%

EPS Next 5Y11.63%

Revenue Next Year13.82%

Revenue Next 2Y12.11%

Revenue Next 3Y10.08%

Revenue Next 5Y9.71%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

With a **Price/Earnings** ratio of **32.44**, **MKTX** can be considered very expensive at the moment.

Compared to the rest of the industry, the **Price/Earnings** ratio of **MKTX** indicates a slightly more expensive valuation: **MKTX** is more expensive than 79.80% of the companies listed in the same industry.

With a **Price/Forward Earnings** ratio of **27.50**, **MKTX** can be considered very expensive at the moment.

Based on the **Price/Forward Earnings** ratio, **MKTX** is valued a bit more expensive than 73.89% of the companies in the same industry.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **21.38**, **MKTX** is valued a bit more expensive.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 32.44 | ||

Fwd PE | 27.5 |

Based on the **Enterprise Value to EBITDA** ratio, **MKTX** is valued a bit cheaper than the industry average as 61.08% of the companies are valued more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 30.12 | ||

EV/EBITDA | 20.21 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

The decent profitability rating of **MKTX** may justify a higher PE ratio.

PEG (NY)3.41

PEG (5Y)3.52

EPS Next 2Y11.48%

EPS Next 3Y11.87%

With a **Dividend Yield** of **1.34**, **MKTX** pays less dividend than the S&P500 average, which is at **2.48**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.34% |

The dividend of **MKTX** is nicely growing with an annual growth rate of **16.59%**!

Dividend Growth(5Y)16.59%

Div Incr Years10

Div Non Decr Years10

DP43.66%

EPS Next 2Y11.48%

EPS Next 3Y11.87%

**MARKETAXESS HOLDINGS INC**

NASDAQ:MKTX (2/22/2024, 2:38:07 PM)

**213.79**

**-1.21 (-0.56%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap8.10B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.34% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 32.44 | ||

Fwd PE | 27.5 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)3.41

PEG (5Y)3.52

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 14.25% | ||

ROE | 20.79% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 43.06% | ||

PM (TTM) | 33.77% | ||

GM | 91.86% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.42

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.11 | ||

Quick Ratio | 2.11 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)2.33%

EPS 3Y-3.29%

EPS 5Y

EPS growth Q2Q

EPS Next Y9.5%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)3.93%

Revenue growth 3Y2.98%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y